Quality of Life and Cancer Clinical Trials
April 20, 2017 - April 21, 2017 | Crowne Plaza Brussels - Le Palace

ANDREW BOTTOMLEY (EORTC, Assistant Director, Head Quality of Life Department) & MARISA MATIAS (Member of the European Parliament)
Chaired by Andrew Bottomley (EORTC, Assistant Director, Head Quality of Life Department) & Marisa Matias (Member of the European Parliament), this conference is free for all attendees and is kindly sponsored by the EORTC Quality of Life Group, and EORTC.
It’s never too late to plan for your next conference, especially to attend free international training by some of the world’s top Quality of Life researchers.
This 2-day conference covers a broad range of topics in HRQOL, PRO, Symptom Research and Cancer Clinical Trials and policies. Bringing together 30 senior PRO international leaders, it will address recent developments of tools as well as other systems for use in clinical trials, and bring a platform to discuss international development and research guidelines. The meeting provides an opportunity to meet the developers of EORTC tools; as well as EU MEPs, policy makers and researchers.
Presentations
The EORTC Director General
General introduction
Key note presentation – What have European politicians done for cancer patients?
General introduction
A global perspective on QOL
General introduction
A broader perspective on Patient-Reported Outcomes from the International Society for Quality of Life Research
Cancer patients and the principles of cancer care
EMA’s oncology PRO guideline – Impact one year on
Cancer patients and the principles of cancer care
Patient reported outcomes in U.S. Regulatory review of cancer therapies
Cancer patients and the principles of cancer care
The Sponsor Perspective on QOL: Current Challenges and Opportunities
Cancer patients and the principles of cancer care
The EORTC Quality of Life Group’s updated strategy
Cancer patients and the principles of cancer care
Cancer patients and the principles of cancer care
Optimizing Quality of Life in cancer clinical trials from an Eastern European perspective
The Role of QOL in Trials that Matter: Canadian Cancer Trials Group
Cancer patients and the principles of cancer care
QoL in breast cancer care – ECIBC experience
Cancer patients and the principles of cancer care
The European Cancer Patients Collation perspective on QOL in the EU
Cancer Patients Experiences in clinical trials
PROMS – Pathway to patient benefit?
Cancer Patients Experiences in clinical trials
Understanding the role of the patient in improving patient information and recruitment across the European Union
Cancer Patients Experiences in clinical trials
The patient’s perspective – Getting out of crisis
Cancer Patients Experiences in clinical trials
The computer-adaptive testing version of the EORTC QLQ-C30
Innovative methods and standardization in cancer research
Looking into the future: Can body worn IT systems and computerized touch screens record cancer survivors’ experiences?
Innovative methods and standardization in cancer research
International standards of Analysis – The SISAQOL initiative
Innovative methods and standardization in cancer research
Moving toward standardization of clinical significance
Innovative methods and standardization in cancer research
Understanding EORTC measures
Innovative methods and standardization in cancer research
PRO-CTCAE and US perspective
Innovative methods and standardization in cancer research
C-Path’s PRO Consortium: A multi-stakeholder approach to PRO assessment in clinical trials
Innovative methods and standardization in cancer research
Missing Data Analysis
Innovative methods and standardization in cancer research
Key EORTC trials and examples of analysis of QOL in clinical trials
Innovative methods and standardization in cancer research
Setting international standards for translation of PRO measures across the EU
Innovative methods and standardization in cancer research
Changes in symptoms and function during cancer treatment
Innovative methods and standardization in cancer research
Sexuality, its measurement and its assessment in EU cancer patients
Innovative methods and standardization in cancer research
Cognitive, neurological impact of cancer in survivors
Innovative methods and standardization in cancer research
Adolescents and young adults with cancer: What determines their well-being?
Innovative methods and standardization in cancer research
What is the current EU cancer survivorship strategy? Current EORTC approach
Cancer Survivorship
Survivorship issues from patient and scientific perspectives?
Cancer Survivorship
Survival: diagnosis or lifestyle?
Cancer Survivorship
Infos
Date | April 20, 2017 - April 21, 2017 |
---|---|
Website: | http:// |
Location: | Crowne Plaza Brussels - Le Palace; |
Category: | Medicine; |